During the past decade, Brussels - HOSP Europe (Ste-Elisabeth) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brussels - HOSP Europe (Ste-Elisabeth)" are "Atrial Fibrillation" (3 trials), "Stroke" (2 trials), "Degenerative Disc Disease" (1 trials), "Intestinal Obstruction" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Brussels - HOSP Europe (Ste-Elisabeth)" in a lesser frequency.

Most popular intervention types in "Brussels - HOSP Europe (Ste-Elisabeth)" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dabigatran Etexilate 150mg" (2 trials), "ASA 100 mg" (1 trials), "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials) and "Dabigatran Etexilate 110mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brussels - HOSP Europe (Ste-Elisabeth)" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Brussels - HOSP Europe (Ste-Elisabeth)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Brussels - HOSP Europe (Ste-Elisabeth), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brussels - HOSP Europe (Ste-Elisabeth), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".